Clinical Trial Update: VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for the VY7523-102 study in Alzheimer's disease, listing Phase 1/Phase 2 and current status as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• VY7523-102

Snippet

Sponsor: Voyager Therapeutics | Conditions: Alzheimer's Disease (AD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING